Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT05190406
Other study ID # Kanagadurga
Secondary ID
Status Recruiting
Phase N/A
First received
Last updated
Start date June 1, 2021
Est. completion date August 1, 2022

Study information

Verified date January 2022
Source Postgraduate Institute of Dental Sciences Rohtak
Contact DR. Pankaj Sangwan, MDS
Phone 9996112202
Email drps_1@yahoo.co.in
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

The purpose of this study is to compare the Success and quality of life following complete pulpotomy and root canal treatment in teeth with clinical signs indicative of irreversible pulpitis.


Description:

After thorough history and clinical and radiographic examination, and confirmation of eligibility for the study, risks and benefits associated with the procedure will be explained and written informed consent will be taken from the patients. Study subjects will be randomly allocated to either Complete pulpotomy or Root canal treatment Group.


Recruitment information / eligibility

Status Recruiting
Enrollment 100
Est. completion date August 1, 2022
Est. primary completion date July 31, 2022
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 14 Years to 60 Years
Eligibility Inclusion Criteria: - Mature permanent restorable mandibular molar teeth. - Tooth should give positive response to pulp sensibility testing. - Clinical diagnosis of irreversible pulpitis with PAI score=2. - Tooth with probing pocket depth and mobility are within normal limits. - Non-contributory medical history. Exclusion Criteria: - Teeth with immature roots. - No pulp exposure after caries excavation. - Bleeding could not be controlled in 6 minutes. - Insufficient bleeding after pulp exposure, the pulp is judged necrotic or partially necrotic. - Absence of antagonist tooth. - Positive history of antibiotic use in the past 1 month or requiring antibiotic prophylaxis - Had taken analgesic in past 3 days. - Tooth with periapical lesion visible on radiograph

Study Design


Related Conditions & MeSH terms


Intervention

Procedure:
Pulpotomy
After achieving hemostasis, in pulpotomy group bioceramic material will be placed and then permanent restoration will be done.
root canal treatment
Single visit root canal treatment will be done according to standard protocol.

Locations

Country Name City State
India Post graduate institute of dental sciences Rohtak Haryana

Sponsors (1)

Lead Sponsor Collaborator
Postgraduate Institute of Dental Sciences Rohtak

Country where clinical trial is conducted

India, 

Outcome

Type Measure Description Time frame Safety issue
Primary Clinical success rate Clinical success criteria No history of spontaneous pain No tenderness to palpation or percussion Normal mobility and probing pocket depth. Soft tissues around tooth are normal with no swelling or sinus tract. 6 months and one year
Primary Radiographic success rate Radiographic success criteria No pathosis evident on the radiograph Periapical Index score 1 or 2 6 months and one year
Secondary Oral Health related quality of Life Oral Health Impact Profile-14 questionnaire of score 0-4 will be used to assess the quality of life. Score 0 means never and 4 means very often affected the quality of life. baseline to one week, 6 months and one year
Secondary Pain assessment Visual analogue Scale of 0 to 10 Centimetere line will be used to assess pain. Score 0 means no pain and Score 10 means maximum pain. baseline to one week
See also
  Status Clinical Trial Phase
Not yet recruiting NCT04585438 - Evaluation of Trans-mucosal Bio-adhesive Discs of Diclofenac Potassium on the Anesthetic Success and Postoperative Pain in Patients With Symptomatic Irreversible Pulpitis: A Randomized Clinical Trial Phase 4
Completed NCT02923687 - Premedication Efficacy of Ketorolac Infiltration on Post Endodontic Pain Phase 2
Completed NCT02614118 - Premedication Efficacy of Oral Ketorolac and Ketorolac/ Acetaminophen on Post Treatment Pain Phase 2
Completed NCT02601911 - Effect of Premedication on Success of Inferior Alveolar Nerve Block Injection Phase 2
Completed NCT01496846 - Efficacy Study of Articaine Versus Lidocaine as Supplemental Infiltration in Inflamed Molars Phase 4
Withdrawn NCT04040127 - Residual Dental Pulp Tissue and Cord Blood Stem Cells Phase 2
Completed NCT06176378 - A Clinical and Radiographic Evaluation of Low-Level Diode Laser Full Pulpotomy in Vital Permanent Teeth N/A
Recruiting NCT04243733 - MTA vs CEM Pulpotomy in Young Permanent Molars N/A
Recruiting NCT06245161 - Efficacy of Computer Controlled Intraosseous Anesthesia in Pediatric Dental Patients N/A
Not yet recruiting NCT06420583 - Post Operative Pain and Oral Health Related Quality of Life Following Pulpotomy VS Extraction of Permanent First Molar N/A
Not yet recruiting NCT04573374 - Comparing the Outcome of Pulpotomy Using Biodentine and Portland Cement in Mature Cases With Irreversible Pulpitis: Randomized Clinical Trial N/A
Completed NCT05778227 - Comparing Different Single and Combination Chelating Agents on Sealer Penetration and Dentin Erosion. N/A
Completed NCT04654845 - Patient Perception Between Two Emergency Treatments of Symptomatic Irreversible Pulpitis. N/A
Recruiting NCT06142799 - Influence of Moment of Restoration in Pain After a Root Canal Treatment N/A
Active, not recruiting NCT06240130 - Outcome Following Use of NaOCl and Chlorhexidine as Wound Lavage Agents N/A
Recruiting NCT06433245 - Outcome Following Use of Different Concentrations of NaOCl as Wound Lavage and Hemostatic Agent in Partial Pulpotomy N/A
Not yet recruiting NCT06427070 - Effectiveness of Two Intracanal Irrigation Solutions N/A
Not yet recruiting NCT05349929 - Analgesic Effect of Anahil and Ibuprofen on Pain After Root Canal Therapy in Patients With Pulpitis of the Molars in Qazvin(a City in Iran) Phase 2
Recruiting NCT06149845 - Pulpotomy in Vital Primary Molars Diagnosed With Symptomatic Irreversible Pulpitis N/A
Completed NCT01561183 - Vital Pulp Therapy (VPT) Using Calcium Enriched Mixture (CEM) to Treat Irreversible Pulpitis N/A